Disturbance [qlco]
Perimenopausal [tmco]
Women [popg]
signs [ftcn]
Renal dysfunction [fndg]
investigate [ftcn]
Associations [menp]
Renal function [ortf]
blood vessel remodeling [ortf]
Evaluate [ftcn]
Metabolic [ftcn]
Hydrodynamic [npop]
Disturbance [qlco]
Cardio-Renal Syndrome [dsyn]
Perimenopausal [tmco]
Women [popg]
Hormone replacement therapy [topp]
Beta [plnt]
Estradiol 1 MG [clnd]
drospirenone 2 MG [clnd]
CORRECTION [inpr]
Disturbance [qlco]
Material [sbst]
Methods [inpr]
Perimenopausal [tmco]
Women [popg]
divided [ftcn]
Group [idcn]
Group I [inpr]
included [ftcn]
premenopausal [tmco]
Women [popg]
Group [idcn]
Ii [aapp]
Women [popg]
Post-Menopause [orgf]
Age [orga]
Group I [inpr]
Cl - [elii]
Group [idcn]
Ii [aapp]
P NOS [aapp, imft]
Age [orga]
Menopause [phsf]
Reach [orgf]
Duration [tmco]
Menopause [phsf]
participants [popg]
Biochemical test [lbpr]
Blood [tisu]
Creatinine [bacs, orch]
Uric Acid [bacs, orch]
Lipid [lipd]
Profile [lbpr]
Glucose tolerance test [diap]
Large artery [bpoc]
elastic [ftcn]
Assessed [acty]
Intima media thickness [clna]
Common carotid artery [bpoc]
Non-invasive [ftcn]
Assessment [hlca]
Endothelial [tisu]
function [phsf]
Measurement [ftcn]
Brachial Artery [bpoc]
Endothelium [tisu]
Dependent [qlco]
Vasodilatation [phsf]
Reactive Hyperemia [patf]
Test [lbpr]
Renal function [ortf]
Assessed [acty]
Glomerular Filtration Rate [diap]
Creatinine clearance [fndg]
Assessed [acty]
Urine test NOS [lbpr]
Strip [medd]
postmenopausal [tmco]
Women [popg]
divided [ftcn]
Group [idcn]
Patients [podg]
Administered [ftcn]
Hat [mnob]
Beta [plnt]
Estradiol 1 MG [clnd]
drospirenone 2 MG [clnd]
Medication [phsu]
Women [popg]
Receive [qlco]
HRT [topp]
Control Group [grup]
End [spco]
Study [mnob]
months [tmco]
Assessment [hlca]
Metabolic [ftcn]
Status [qlco]
body mass [fndg]
Endothelial [tisu]
function [phsf]
Common carotid artery [bpoc]
Intima media thickness [clna]
Repeated [ftcn]
postmenopausal [tmco]
Women [popg]
Lipid [lipd]
Carbohydrate Metabolism [moft]
Disturbance [qlco]
Observed [ftcn]
Metabolic syndrome [dsyn]
Lipid Metabolism [moft]
Disturbance [qlco]
Observed [ftcn]
Pre-Menopause [phsf]
Reach [orgf]
Maximum [qnco]
Post-Menopause [orgf]
postmenopausal [tmco]
Women [popg]
Compared [acty]
peers [popg]
Pre-Menopause [phsf]
Fasting [fndg]
Postprandial [tmco]
Levels [qlco]
Blood Glucose [carb]
Structural [spco]
Functional [ftcn]
Blood vessel wall [bpoc]
Severe [qlco]
postmenopausal [tmco]
premenopausal [tmco]
Women [popg]
P NOS [aapp, imft]
Blood Flow Velocity [lbtr]
Reactive Hyperemia [patf]
Test [lbpr]
Group [idcn]
postmenopausal [tmco]
Women [popg]
Brachial Artery [bpoc]
Endothelium [tisu]
Dependent [qlco]
Vasodilatation [phsf]
premenopausal [tmco]
Females [fndg]
Point [qnco]
Decrease [qlco]
Brachial Artery [bpoc]
Sensitivity [qnco]
Endothelial [tisu]
shear stress [npop]
Women [popg]
Post-Menopause [orgf]
Reduced [qlco]
Glomerular Filtration Rate [diap]
Observed [ftcn]
postmenopausal [tmco]
Women [popg]
Registered [hlca]
premenopausal [tmco]
Women [popg]
Normal [qlco]
Glomerular Filtration Rate [diap]
postmenopausal [tmco]
Females [fndg]
Independent [idcn]
Reduced [qlco]
Glomerular Filtration Rate [diap]
Suggest [idcn]
Proportion [qnco]
Women [popg]
Subclinical [qlco]
Renal injury [inpo]
manifestation [ftcn]
Target [ftcn]
Organ [bpoc]
Damage [inpo]
Associations [menp]
Vascular structure [bpoc]
function [phsf]
Renal function [ortf]
Main [qlco]
Metabolic syndrome [dsyn]
Components [mnob]
Hat [mnob]
Beta [plnt]
Estradiol 1 MG [clnd]
drospirenone 2 MG [clnd]
effects [qlco]
Obesity, Visceral [sosy]
Metabolic [ftcn]
Status [qlco]
Arterial structure [bpoc]
function [phsf]
